Minister of State (Minister for Health and Secondary Care)

The Rt Hon Andrew Stephenson CBE MP

Biography

Andrew Stephenson was appointed Minister of State in the Department of Health and Social Care on 13 November 2023.

He was previously Government Whip (Lord Commissioner of HM Treasury) from 27 October 2022 to 13 November 2023.

He was Parliamentary Under Secretary of State at the Department for Levelling Up, Housing and Communities from 20 September 2022 to 27 October 2022, Minister without Portfolio at the Cabinet Office between 7 July 2022 and 6 September 2022, Minister of State at the Department for Transport from 13 February 2020 to July 2022 and Minister of State at the Foreign and Commonwealth Office and the Department for International Development from 25 July 2019 to 13 February 2020. He was first elected as Conservative MP for Pendle in May 2010.

He was a Parliamentary Under Secretary of State at the Department for Business, Energy and Industrial Strategy from 4 April 2019 to 25 July 2019. He was also a Government Whip, Vice Chamberlain (HM Household) from 26 July 2018 to 4 April 2019 and served as an Assistant Government Whip from June 2017 to January 2018.

Minister of State (Minister for Health and Secondary Care)

The Minister of State for Health and Secondary Care is responsible for:

  • NHS secondary care:
    • elective care recovery
    • hospital reconfigurations
    • special measures regimes
  • major diseases
    • cancer
    • diabetes
    • stroke
  • rare diseases
  • screening
  • long-term conditions
  • NHS workforce:
    • recruitment and retention
    • supply, education and training
    • leadership
    • pay and pensions
    • overall lead for industrial relations
  • research:
    • National Institute for Health and Care Research (NIHR)
    • genomics, genetics and regenerative medicine
    • clinical trials
  • life sciences
  • medicines and medicines regulation:
    • pharmaceutical price regulation schemes
    • uptake of new drugs
    • medical technology
    • medicines supply
    • medicinal cannabis
    • antivirals and therapeutics
  • international, devolved administrations, crown dependencies and overseas territories
  • Parliamentary business
  • sponsorship of:
    • National Institute for Health and Care Excellence (NICE)
    • Medicines and Healthcare products Regulatory Agency (MHRA)
    • Health Research Authority (HRA)
    • NHS England

More about this role

Department of Health and Social Care